Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease

被引:122
|
作者
Guo, Bing [1 ,2 ]
Guo, Yuming [3 ]
Nima, Qucuo [4 ]
Feng, Yuemei [5 ]
Wang, Ziyun [6 ]
Lu, Rong [7 ]
Baimayangji [8 ]
Ma, Yue [1 ,2 ]
Zhou, Junmin [1 ,2 ]
Xu, Huan [1 ,2 ]
Chen, Lin [1 ,2 ]
Chen, Gongbo [9 ,10 ]
Li, Shanshan [3 ]
Tong, Huan [11 ,12 ]
Ding, Xianbin [13 ]
Zhao, Xing [1 ,2 ]
机构
[1] Sichuan Univ, West China Sch Publ Hlth, 16,Sect 3,Renmin South Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp 4, 16,Sect 3,Renmin South Rd, Chengdu 610041, Sichuan, Peoples R China
[3] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
[4] Tibet Ctr Dis Control & Prevent, Lhasa, Tibet, Peoples R China
[5] Kunming Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Kunming, Yunnan, Peoples R China
[6] Guizhou Med Univ, Sch Publ Hlth, Key Lab Environm Pollut Monitoring & Dis Control, Minist Educ, Guiyang, Guizhou, Peoples R China
[7] Chengdu Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China
[8] Tibet Univ, Lhasa, Tibet, Peoples R China
[9] Sun Yat Sen Univ, Guangdong Prov Engn Technol Res Ctr Environm & Hl, Guangzhou, Guangdong, Peoples R China
[10] Sun Yat Sen Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Guangzhou, Guangdong, Peoples R China
[11] Sichuan Univ, West China Hosp, Dept Gastroenterol, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[12] Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[13] Chongqing Municipal Ctr Dis Control & Prevent, Chongqing 400042, Peoples R China
基金
中国国家自然科学基金; 英国医学研究理事会; 中国博士后科学基金;
关键词
Metabolic-associated fatty liver disease; MAFLD; air pollution; epidemiologic study; PARTICULATE MATTER EXPOSURE; LONG-TERM EXPOSURE; SIZE; INFLAMMATION; CHINA; ACTIVATION; HEALTH; PM2.5; PM1;
D O I
10.1016/j.jhep.2021.10.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Accumulating animal studies have demonstrated the harmful contribution of ambient air pollution (AP) to metabolic dysfunction-associated fatty liver disease (MAFLD), but corresponding epidemiological evidence is limited. We examined the associations between long-term AP exposure and MAFLD prevalence in a Chinese population. Methods: We conducted a cross-sectional study of 90,086 participants recruited in China from 2018 to 2019. MAFLD was assessed based on radiologically diagnosed hepatic steatosis and the presence of overweight/obese status, diabetes mellitus, or metabolic dysregulation. Residence-specific levels of air pollutants, including particulate matter with aerodynamic diameters of <= 1 mu m (PM1), <= 2.5 mu m (PM2.5), and <= 10 mu m (PM10), and nitrogen dioxide (NO2), were estimated by validated spatiotemporal models. We used logistic regression models to examine the AP-MAFLD associations and further evaluated potential effect modifications by demographics, lifestyle, central obesity, and diabetes status. Results: Increased exposure levels to all 4 air pollutants were significantly associated with increased odds of MAFLD, with odds ratios (ORs) of 1.13 (95% CI 1.10-1.17), 1.29 (1.25-1.34), 1.11 (1.09-1.14), and 1.15 (1.12-1.17) for each 10 mu g/m(3) increase in PM1, PM2.5, PM10, and NO2, respectively. Further stratified analyses revealed that individuals who are male, alcohol drinkers, and current and previous smokers, those who consume a high-fat diet, and those with central obesity experience more significant adverse effects from AP exposure than other individuals. Conclusions: This study provides evidence that long-term exposure to ambient PM1, PM2.5, PM10, and NO2 may increase the odds of MAFLD in the real world. These effects may be exacerbated by unhealthy lifestyle habits and central obesity. Lay summary: We conducted an epidemiological study on the potential effect of ambient air pollution on the risk of metabolic dysfunction-associated fatty liver disease (MAFLD) in approximately 90 thousand adults in China. We found that long-term exposure to ambient air pollution may increase the odds of MAFLD, especially in individuals who are male, smokers, and alcohol drinkers, those who consume a high-fat diet, and those with central obesity. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
引用
收藏
页码:518 / 525
页数:9
相关论文
共 50 条
  • [1] Comment on "Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease"
    Chen, Yu-Syuan
    Hung, Yao-Min
    Wei, James Cheng-Chung
    JOURNAL OF HEPATOLOGY, 2022, 77 (01) : 259 - 260
  • [2] Reply to: "Comment on "Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease""
    Guo, Bing
    Zhou, Junmin
    Zhao, Xing
    JOURNAL OF HEPATOLOGY, 2022, 77 (01) : 260 - 262
  • [3] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [4] Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
    Lei, Fang
    Wang, Xiao-Ming
    Wang, Changquan
    Huang, Xuewei
    Liu, Ye-Mao
    Qin, Juan-Juan
    Zhang, Peng
    Ji, Yan-Xiao
    She, Zhi-Gang
    Cai, Jingjing
    Li, Huo-ping
    Zhang, Xiao-Jing
    Li, Hongliang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Metabolic dysfunction-associated fatty liver disease is associated with increased risk of extrahepatic malignancies: a nationwide cohort study
    Park, Min Kyung
    Moon, Hye-Sung
    Chung, Sungwon
    Won, Sungho
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S630 - S630
  • [6] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
  • [7] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [8] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF LIVER-RELATED COMPLICATIONS: A NATIONWIDE COHORT STUDY
    Shin, Hyunjae
    Park, Min Kyung
    Moon, Hye-Sung
    Chung, Sung Won
    Ko, Yunmi
    Park, Youngsu
    Park, Jeayeon
    Hur, Moon Haeng
    Bin Lee, Yun
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    HEPATOLOGY, 2023, 78 : S1012 - S1013
  • [9] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Hong Fan
    Lili Li
    Zhenqiu Liu
    Pengyan Zhang
    Sheng Wu
    Xinyu Han
    Xingdong Chen
    Chen Suo
    Liou Cao
    Tiejun Zhang
    BMC Gastroenterology, 23
  • [10] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Fan, Hong
    Li, Lili
    Liu, Zhenqiu
    Zhang, Pengyan
    Wu, Sheng
    Han, Xinyu
    Chen, Xingdong
    Suo, Chen
    Cao, Liou
    Zhang, Tiejun
    BMC GASTROENTEROLOGY, 2023, 23 (01)